Advertisement

Cross-Reactivity Studies of rMOGED with Synthetic Putative Autoantigens CSF114(Glc) and [N31(Glc)]hMOG(30–50) in Multiple Sclerosis Patients’ Sera

  • Barbara Mulinacci
  • Constanze Breithaupt
  • Prajna P. Pal
  • Nedijlko Budisa
  • Marta Pazzagli
  • Benedetta Mazzanti
  • Paolo Rovero
  • Luis Moroder
  • Anna M. Papini
Conference paper
Part of the American Peptide Symposia book series (APSY, volume 9)

Keywords

Multiple Sclerosis Multiple Sclerosis Patient Myelin Protein Myelin Oligodendrocyte Glycoprotein Huisgen Cycloaddition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Papini, A. M. Nature Medicine 11, 1 (2005).CrossRefGoogle Scholar
  2. 2.
    Lolli, F., et al. Proc. Natl. Acad. Sci. USA 102 10273–10278 (2005).PubMedCrossRefGoogle Scholar
  3. 3.
    Lolli, F., et al J. Neuroimmunol. 167, 131–137 (2005).PubMedCrossRefGoogle Scholar
  4. 4.
    Papini, A. M., Rovero, P., Chelli, M. and Lolli, F. PCT International application (2003) WO 03000733 A2. Priority Data FI2001A000114.Google Scholar
  5. 5.
    Mazzucco, S., et al. Bioorg. Med. Chem. Lett. 9, 167–172, (1999).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Barbara Mulinacci
    • 1
    • 2
  • Constanze Breithaupt
    • 2
  • Prajna P. Pal
    • 2
  • Nedijlko Budisa
    • 2
  • Marta Pazzagli
    • 1
  • Benedetta Mazzanti
    • 1
  • Paolo Rovero
    • 1
  • Luis Moroder
    • 2
  • Anna M. Papini
    • 1
  1. 1.Laboratory of Peptide & Protein Chemistry & Biology, Polo ScientificoUniversità di FirenzeSesto Fiorentino (FI)Italy
  2. 2.Max-Planck-Institut für BiochemieMartinsriedGermany

Personalised recommendations